NCT01596673
- Conditions
- Chemically-Induced Disorders, Drug Abuse, Mental Disorders, +1 more
- Locations
-
- Cephalon Investigational Site 001 Salt Lake City, Utah, United States
- Cephalon Investigational Site 100 Toronto, Ontario, Canada
Clinical trial condition
Explore clinical trials studying Drug Abuse. Study availability and eligibility vary by location and protocol.
NCT01596673
NCT00198874
NCT00723749
Not specified
NCT00671632
NCT00776685
NCT00344474
NCT00350909
NCT00383838
Not specified